Uterine Sarcoma Clinical Trials & Research

Scientists at Memorial Sloan Kettering are working to develop more-effective therapies for women with uterine sarcomas through clinical trials and research.

In clinical trials, medical experts and researchers evaluate the safety and effectiveness of new therapies and diagnostic tools. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere.

MSK also advances discoveries through participation and leadership in major research organizations around the world.

Uterine Sarcoma Clinical Trials Currently Enrolling Patients

To learn more about a study, choose from the list below.

and/or
3 Clinical Trials found
Researchers want to find the best dose of VLS-1488 to treat various types of advanced cancer. VLS-1488 blocks KIF18A, a protein that plays a role in the rapid growth of cancer cells. By blocking KIF18A, VLS-1488 may cause cancer cells to stop growing and die. VLS-1488 is taken orally (by mouth).
Leiomyosarcoma is a type of cancer that forms in smooth muscle. Researchers want to see if adding ADI-PEG 20 to the usual chemotherapy for leiomyosarcoma works better than chemotherapy alone. The people in this study have leiomyosarcoma that keeps growing despite treatment.
This purpose of this study is to assess whether adding trastuzumab/hyaluronidase-oysk or pertuzumab/trastuzumab/hyaluronidase-zzxf to the usual chemotherapy (paclitaxel and carboplatin) shrinks tumors in patients with HER2-positive endometrial serous carcinoma or carcinosarcoma.